| FDM | 表記: | 3'-FLUORO-3'-DEOXYTHYMIDINE MONOPHOSPHATE | 組成式: | C10 H14 F N2 O7 P | SMILES: | O=C1NC(=O)N(C=C1C)C2OC(C(F)C2)COP(=O)(O)O | InChi: | InChI=1S/C10H14FN2O7P/c1-5-3-13(10(15)12-9(5)14)8-2-6(11)7(20-8)4-19-21(16,17)18/h3,6-8H,2,4H2,1H3,(H,12,14,15)(H2,16,17,18)/t6-,7+,8+/m0/s1 | 別名: | PHOSPHORIC ACID MONO-[3-FLUORO-5-(5-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-TETRAHYRO-FURAN-2-YLMETHYL] ESTER | 定義日: | 2003-01-14 | 最終更新日: | 2021-03-13 | 識別子(ID): | 3'-deoxy-3'-fluorothymidine 5'-(dihydrogen phosphate) |
|
| FDN | 表記: | (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE | 組成式: | C16 H12 F2 N2 O3 | SMILES: | O=C2OC(C(=O)N2Nc1ccccc1)(c3ccc(F)cc3F)C | InChi: | InChI=1S/C16H12F2N2O3/c1-16(12-8-7-10(17)9-13(12)18)14(21)20(15(22)23-16)19-11-5-3-2-4-6-11/h2-9,19H,1H3/t16-/m0/s1 | 別名: | 5-(2,4-DIFLUORO-PHENYL)-5-METHYL-3-PHENYLAMINO-OXAZOLIDINE-2,4-DIONE | 定義日: | 2006-02-10 | 最終更新日: | 2021-03-13 | 識別子(ID): | (5S)-5-(2,4-difluorophenyl)-5-methyl-3-(phenylamino)-1,3-oxazolidine-2,4-dione |
|
| FFG | 表記: | (R)-6-(2'-((3-hydroxypyrrolidin-1-yl)methyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1h-pyrazolo[3,4-c]pyridin-7(4h)-one | 組成式: | C32 H28 F3 N7 O3 | SMILES: | O=C1NC(=NN1)c2cc(ccc2)n7nc(c6c7C(=O)N(c5ccc(c3ccccc3CN4CCC(O)C4)cc5)CC6)C(F)(F)F | InChi: | InChI=1S/C32H28F3N7O3/c33-32(34,35)28-26-13-15-41(30(44)27(26)42(39-28)23-6-3-5-20(16-23)29-36-31(45)38-37-29)22-10-8-19(9-11-22)25-7-2-1-4-21(25)17-40-14-12-24(43)18-40/h1-11,16,24,43H,12-15,17-18H2,(H2,36,37,38,45)/t24-/m1/s1 | 別名: | 6-(2'-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}biphenyl-4-yl)-1-[3-(5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)phenyl]-3-(trifluoromethyl)-1,4,5,6-tetrahydro-7H-pyrazolo[3,4-c]pyridin-7-one | 定義日: | 2008-12-04 | 最終更新日: | 2021-03-13 | 識別子(ID): | 6-(2'-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}biphenyl-4-yl)-1-[3-(5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)phenyl]-3-(trifluoromethyl)-1,4,5,6-tetrahydro-7H-pyrazolo[3,4-c]pyridin-7-one |
|
| 29N | 表記: | 1,1',1''-(1,3,5-triazinane-1,3,5-triyl)tripropan-1-one | 組成式: | C12 H21 N3 O3 | SMILES: | O=C(N1CN(C(=O)CC)CN(C(=O)CC)C1)CC | InChi: | InChI=1S/C12H21N3O3/c1-4-10(16)13-7-14(11(17)5-2)9-15(8-13)12(18)6-3/h4-9H2,1-3H3 | 別名: | 1,1',1''-(1,3,5-triazinane-1,3,5-triyl)triprop-2-en-1-one, bound form | 定義日: | 2013-09-12 | 最終更新日: | 2021-03-13 | 公開日: | 2014-02-05 | 識別子(ID): | 1,1',1''-(1,3,5-triazinane-1,3,5-triyl)tripropan-1-one |
|
| 2DD | 表記: | 3-(5-CHLORO-2,4-DIHYDROXY-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID 4-SULFAMOYL-BENZYLAMIDE | 組成式: | C17 H15 Cl N4 O5 S | SMILES: | O=S(=O)(N)c1ccc(cc1)CNC(=O)c3cnnc3c2c(O)cc(O)c(Cl)c2 | InChi: | InChI=1S/C17H15ClN4O5S/c18-13-5-11(14(23)6-15(13)24)16-12(8-21-22-16)17(25)20-7-9-1-3-10(4-2-9)28(19,26)27/h1-6,8,23-24H,7H2,(H,20,25)(H,21,22)(H2,19,26,27) | 別名: | N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE | 定義日: | 2005-08-02 | 最終更新日: | 2021-03-13 | 識別子(ID): | 5-(5-chloro-2,4-dihydroxyphenyl)-N-(4-sulfamoylbenzyl)-1H-pyrazole-4-carboxamide |
|
| 2DT | 表記: | 3'-DEOXYTHYMIDINE-5'-MONOPHOSPHATE | 組成式: | C10 H15 N2 O7 P | SMILES: | O=C1NC(=O)N(C=C1C)C2OC(CC2)COP(=O)(O)O | InChi: | InChI=1S/C10H15N2O7P/c1-6-4-12(10(14)11-9(6)13)8-3-2-7(19-8)5-18-20(15,16)17/h4,7-8H,2-3,5H2,1H3,(H,11,13,14)(H2,15,16,17)/t7-,8+/m0/s1 | 別名: | 2',3'-DIDEOXYTHYMIDINE-5'-MONOPHOSPHATE | 定義日: | 1999-07-07 | 最終更新日: | 2021-03-13 | 識別子(ID): | [(2S,5R)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl dihydrogen phosphate |
|
| 2FR | 表記: | 3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide | 組成式: | C24 H25 N5 O | SMILES: | O=C(N)CCc1cc(ccc1)n4nc(c2c4cc(nc2)NC(c3ccccc3)C)C | InChi: | InChI=1S/C24H25N5O/c1-16(19-8-4-3-5-9-19)27-24-14-22-21(15-26-24)17(2)28-29(22)20-10-6-7-18(13-20)11-12-23(25)30/h3-10,13-16H,11-12H2,1-2H3,(H2,25,30)(H,26,27)/t16-/m0/s1 | 別名: | 3-{3-[3-methyl-6-(1-phenyl-ethylamino)-pyrazolo[4,3-c]pyridin-1-yl]-phenyl}-propionamide | 定義日: | 2008-06-16 | 最終更新日: | 2021-03-13 | 識別子(ID): | 3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide |
|
| 2HI | 表記: | (2S,3R)-2,7-DIHYDROXY-3-(4-HYDROXYPHENYL)-2,3-DIHYDRO-4H-CHROMEN-4-ONE | 組成式: | C15 H12 O5 | SMILES: | O=C1c3c(OC(O)C1c2ccc(O)cc2)cc(O)cc3 | InChi: | InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-14(18)11-6-5-10(17)7-12(11)20-15(13)19/h1-7,13,15-17,19H/t13-,15-/m0/s1 | 別名: | 2,7,4'-TRIHYDROXYISOFLAVANONE | 定義日: | 2005-04-26 | 最終更新日: | 2021-03-13 | 識別子(ID): | (2S,3R)-2,7-dihydroxy-3-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one |
|
| 2IH | 表記: | 1,1'-HEXANE-1,6-DIYLBIS(1H-IMIDAZOLE) | 組成式: | C12 H18 N4 | SMILES: | n1ccn(c1)CCCCCCn2ccnc2 | InChi: | InChI=1S/C12H18N4/c1(3-7-15-9-5-13-11-15)2-4-8-16-10-6-14-12-16/h5-6,9-12H,1-4,7-8H2 | 別名: | 1,6-DI(IMIDAZOL-1-YL)HEXANE | 定義日: | 2006-06-29 | 最終更新日: | 2021-03-13 | 識別子(ID): | 1,1'-hexane-1,6-diylbis(1H-imidazole) |
|
| 2K8 | 表記: | (6R)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridine-6-carboxylic acid | 組成式: | C7 H9 N5 O3 | SMILES: | O=C(O)C2NC1=C(N=C(N)NC1=O)NC2 | InChi: | InChI=1S/C7H9N5O3/c8-7-11-4-3(5(13)12-7)10-2(1-9-4)6(14)15/h2,10H,1H2,(H,14,15)(H4,8,9,11,12,13)/t2-/m1/s1 | 別名: | 6-carboxy-5,6,7,8-tetrahydropterin | 定義日: | 2013-11-14 | 最終更新日: | 2021-03-13 | 公開日: | 2013-12-25 | 識別子(ID): | (6R)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridine-6-carboxylic acid |
|
| 2LR | 表記: | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(1R,2S)-1-hydroxy-4-methyl-1-[(2R)-2-methyloxiran-2-yl]pentan-2-yl}-L-leucinamide | 組成式: | C29 H47 N3 O6 | SMILES: | O=C(OCc1ccccc1)NC(C(=O)NC(C(=O)NC(C(O)C2(OC2)C)CC(C)C)CC(C)C)CC(C)C | InChi: | InChI=1S/C29H47N3O6/c1-18(2)13-22(25(33)29(7)17-38-29)30-26(34)23(14-19(3)4)31-27(35)24(15-20(5)6)32-28(36)37-16-21-11-9-8-10-12-21/h8-12,18-20,22-25,33H,13-17H2,1-7H3,(H,30,34)(H,31,35)(H,32,36)/t22-,23-,24-,25+,29+/m0/s1 | 別名: | PHQ-LEU-LEU-LEU-EPOXYKETONE, unbound form | 定義日: | 2013-11-28 | 最終更新日: | 2021-03-13 | 公開日: | 2014-02-12 | 識別子(ID): | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(1R,2S)-1-hydroxy-4-methyl-1-[(2R)-2-methyloxiran-2-yl]pentan-2-yl}-L-leucinamide |
|
| FFQ | 表記: | [(1R)-1-hydroxypropyl]phosphonic acid | 組成式: | C3 H9 O4 P | SMILES: | O=P(O)(O)C(O)CC | InChi: | InChI=1S/C3H9O4P/c1-2-3(4)8(5,6)7/h3-4H,2H2,1H3,(H2,5,6,7)/t3-/m1/s1 | 別名: | Fosfomycin, bound form | 定義日: | 2011-02-18 | 最終更新日: | 2021-03-13 | 識別子(ID): | [(1R)-1-hydroxypropyl]phosphonic acid |
|
| FGF | 表記: | N-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-methanoyl-6-[(4-methyl-2-oxidanylidene-piperazin-1-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | 組成式: | C25 H30 N8 O4 | SMILES: | COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc23)ncc1C#N | InChi: | InChI=1S/C25H30N8O4/c1-31-7-8-32(23(35)15-31)14-18-10-17-4-3-6-33(24(17)29-21(18)16-34)25(36)30-22-11-20(27-5-9-37-2)19(12-26)13-28-22/h10-11,13,16H,3-9,14-15H2,1-2H3,(H2,27,28,30,36) | 別名: | Roblitinib | 定義日: | 2019-04-02 | 最終更新日: | 2021-03-13 | 公開日: | 2019-05-15 | 識別子(ID): | ~{N}-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-methanoyl-6-[(4-methyl-2-oxidanylidene-piperazin-1-yl)methyl]-3,4-dihydro-2~{H}-1,8-naphthyridine-1-carboxamide |
|
| FGV | 表記: | (1R,2S,3r,4R,5S,6s)-2,4,6-trihydroxycyclohexane-1,3,5-triyl tris[dihydrogen (phosphate)] | 組成式: | C6 H15 O15 P3 | SMILES: | C1(C(O)C(OP(O)(O)=O)C(O)C(C1O)OP(=O)(O)O)OP(O)(O)=O | InChi: | InChI=1S/C6H15O15P3/c7-1-4(19-22(10,11)12)2(8)6(21-24(16,17)18)3(9)5(1)20-23(13,14)15/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/t1-,2-,3-,4-,5+,6- | 別名: | D-myo-inositol-1,3,5-trisphosphate | 定義日: | 2018-03-30 | 最終更新日: | 2021-03-13 | 公開日: | 2018-10-24 | 識別子(ID): | (1R,2S,3r,4R,5S,6s)-2,4,6-trihydroxycyclohexane-1,3,5-triyl tris[dihydrogen (phosphate)] |
|
| FJV | 表記: | 4-(8-(piperazin-1-yl)-1,2,3,4-tetrahydro-[1,2,3]triazino[4',5':4,5]thieno[2,3-c]isoquinolin-5-yl)morpholine | 組成式: | C20 H25 N7 O S | SMILES: | C1COCCN1c3c2CCCCc2c4c(n3)sc5c4nnnc5N6CCNCC6 | InChi: | InChI=1S/C20H25N7OS/c1-2-4-14-13(3-1)15-16-17(19(24-25-23-16)26-7-5-21-6-8-26)29-20(15)22-18(14)27-9-11-28-12-10-27/h21H,1-12H2 | 別名: | 5-(morpholin-4-yl)-8-(piperazin-1-yl)-1,2,3,4-tetrahydro[1,2,3]triazino[4',5':4,5]thieno[2,3-c]isoquinoline | 定義日: | 2018-04-05 | 最終更新日: | 2021-03-13 | 公開日: | 2019-04-17 | 識別子(ID): | 5-(morpholin-4-yl)-8-(piperazin-1-yl)-1,2,3,4-tetrahydro[1,2,3]triazino[4',5':4,5]thieno[2,3-c]isoquinoline |
|
| FM6 | 表記: | [(1S)-1-(3,4-dichlorophenyl)-3-[oxidanyl(phenylcarbonyl)amino]propyl]phosphonic acid | 組成式: | C16 H16 Cl2 N O5 P | SMILES: | Clc1ccc(cc1Cl)C(CCN(O)C(=O)c2ccccc2)P(=O)(O)O | InChi: | InChI=1S/C16H16Cl2NO5P/c17-13-7-6-12(10-14(13)18)15(25(22,23)24)8-9-19(21)16(20)11-4-2-1-3-5-11/h1-7,10,15,21H,8-9H2,(H2,22,23,24)/t15-/m0/s1 | 別名: | [3-[benzoyl(hydroxy)amino]-1-(3,4-dichlorophenyl)propyl]phosphonic acid | 定義日: | 2012-12-30 | 最終更新日: | 2021-03-13 | 公開日: | 2013-10-09 | 識別子(ID): | [(1S)-3-[benzoyl(hydroxy)amino]-1-(3,4-dichlorophenyl)propyl]phosphonic acid |
|
| FOF | 表記: | (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol | 組成式: | C15 H26 O | SMILES: | CC(=CCCC(=CCCC(C)=[C@H]CO)C)C | InChi: | InChI=1S/C15H26O/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h7,9,11,16H,5-6,8,10,12H2,1-4H3/b14-9+,15-11+ | 別名: | trans,trans-Farnesol | 定義日: | 2019-02-08 | 最終更新日: | 2021-03-13 | 公開日: | 2019-02-20 | 識別子(ID): | (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol |
|
| FOH | 表記: | (2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol | 組成式: | C15 H26 O | SMILES: | C/C(C)=C/CCC(=C/CCC(C)=[C@H]CO)C | InChi: | InChI=1S/C15H26O/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h7,9,11,16H,5-6,8,10,12H2,1-4H3/b14-9-,15-11- | 別名: | cis,cis-Farnesol | 定義日: | 1999-12-08 | 最終更新日: | 2021-03-13 | 識別子(ID): | (2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol |
|
| FOI | 表記: | methyl 3-{[(5S)-1-(hydroxyamino)-5H-inden-5-yl]amino}furo[2,3-c]pyridine-2-carboxylate | 組成式: | C18 H15 N3 O4 | SMILES: | O=C(OC)c2oc1cnccc1c2NC4C=CC3=C(NO)C=CC3=C4 | InChi: | InChI=1S/C18H15N3O4/c1-24-18(22)17-16(13-6-7-19-9-15(13)25-17)20-11-3-4-12-10(8-11)2-5-14(12)21-23/h2-9,11,20-21,23H,1H3/t11-/m0/s1 | 別名: | (E)-methyl 3-(1-(hydroxyimino)-2,3-dihydro-1H-inden-5-ylamino)furo[2,3-c]pyridine-2-carboxylate | 定義日: | 2010-12-01 | 最終更新日: | 2021-03-13 | 識別子(ID): | methyl 3-{[(5S)-1-(hydroxyamino)-5H-inden-5-yl]amino}furo[2,3-c]pyridine-2-carboxylate |
|
| FSD | 表記: | amicetin | 組成式: | C29 H42 N6 O9 | SMILES: | CC1OC(CCC1OC2C(C(C(C(C)O2)N(C)C)O)O)N4C=CC(NC(=O)c3ccc(cc3)NC(C(C)(CO)N)=O)=NC4=O | InChi: | InChI=1S/C29H42N6O9/c1-15-19(44-26-24(38)23(37)22(34(4)5)16(2)43-26)10-11-21(42-15)35-13-12-20(33-28(35)41)32-25(39)17-6-8-18(9-7-17)31-27(40)29(3,30)14-36/h6-9,12-13,15-16,19,21-24,26,36-38H,10-11,14,30H2,1-5H3,(H,31,40)(H,32,33,39,41)/t15-,16-,19+,21-,22-,23+,24-,26-,29+/m1/s1 | 別名: | (4S)-N-{(4S)-1-[(2R,5S,6R)-5-{[4,6-dideoxy-4-(dimethylamino)-alpha-D-glucopyranosyl]oxy}-6-methyloxan-2-yl]-2-oxo-1,2,3,4-tetrahydropyrimidin-4-yl}-4-[(2-methyl-D-seryl)amino]cyclohexa-1,5-diene-1-carboxamide | 定義日: | 2018-04-16 | 最終更新日: | 2021-03-13 | 公開日: | 2019-04-10 | 識別子(ID): | N-{1-[(2R,5S,6R)-5-{[4,6-dideoxy-4-(dimethylamino)-alpha-D-glucopyranosyl]oxy}-6-methyloxan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}-4-[(2-methyl-L-seryl)amino]benzamide |
|
| FSY | 表記: | fevipiprant | 組成式: | C19 H17 F3 N2 O4 S | SMILES: | OC(Cc1c3c(n(c1C)Cc2ccc(cc2C(F)(F)F)S(=O)(=O)C)nccc3)=O | InChi: | InChI=1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26) | 別名: | (2-methyl-1-{[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl}-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid | 定義日: | 2018-04-16 | 最終更新日: | 2021-03-13 | 公開日: | 2018-10-03 | 識別子(ID): | (2-methyl-1-{[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl}-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid |
|
| FTN | 表記: | N-[3-(1-methylethoxy)phenyl]-2-(trifluoromethyl)benzamide | 組成式: | C17 H16 F3 N O2 | SMILES: | CC(C)Oc1cccc(NC(=O)c2ccccc2C(F)(F)F)c1 | InChi: | InChI=1S/C17H16F3NO2/c1-11(2)23-13-7-5-6-12(10-13)21-16(22)14-8-3-4-9-15(14)17(18,19)20/h3-11H,1-2H3,(H,21,22) | 別名: | flutolanil | 定義日: | 2010-02-19 | 最終更新日: | 2021-03-13 | 識別子(ID): | N-(3-propan-2-yloxyphenyl)-2-(trifluoromethyl)benzamide |
|
| FTO | 表記: | ~{tert}-butyl ~{N}-[(2~{S},3~{R},5~{R})-6-[[(2~{S})-1-[[(2~{S})-1-azanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-oxidanyl-6-oxidanylidene-1-phenyl-5-(phenylmethyl)hexan-2-yl]carbamate | 組成式: | C39 H52 N4 O6 | SMILES: | CC(C)C[CH](NC(=O)[CH](C[CH](O)[CH](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc2ccccc2)C(=O)N[CH](Cc3ccccc3)C(N)=O | InChi: | InChI=1S/C39H52N4O6/c1-26(2)21-33(37(47)41-32(35(40)45)24-29-19-13-8-14-20-29)42-36(46)30(22-27-15-9-6-10-16-27)25-34(44)31(23-28-17-11-7-12-18-28)43-38(48)49-39(3,4)5/h6-20,26,30-34,44H,21-25H2,1-5H3,(H2,40,45)(H,41,47)(H,42,46)(H,43,48)/t30-,31+,32+,33+,34-/m1/s1 | 別名: | L-685,458 | 定義日: | 2020-06-15 | 最終更新日: | 2021-03-13 | 公開日: | 2021-01-27 | 識別子(ID): | ~{tert}-butyl ~{N}-[(2~{S},3~{R},5~{R})-6-[[(2~{S})-1-[[(2~{S})-1-azanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-oxidanyl-6-oxidanylidene-1-phenyl-5-(phenylmethyl)hexan-2-yl]carbamate |
|
| 5H8 | 表記: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-3-methyl-L-valine | 組成式: | C21 H34 N3 O7 P | SMILES: | c1ccc(COC(=O)NCP(=O)(O)NC(C(NC(C(=O)O)C(C)(C)C)=O)CC(C)C)cc1 | InChi: | InChI=1S/C21H34N3O7P/c1-14(2)11-16(18(25)23-17(19(26)27)21(3,4)5)24-32(29,30)13-22-20(28)31-12-15-9-7-6-8-10-15/h6-10,14,16-17H,11-13H2,1-5H3,(H,22,28)(H,23,25)(H,26,27)(H2,24,29,30)/t16-,17+/m0/s1 | 別名: | (6S,9S)-1-(benzyloxy)-9-(tert-butyl)-6-isobutyl-4-oxido-1,4,7-trioxo-2,5,8-triaza-4-phosphadecan-10-oate | 定義日: | 2015-09-25 | 最終更新日: | 2021-03-13 | 公開日: | 2015-10-28 | 識別子(ID): | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-3-methyl-L-valine |
|
| 5H9 | 表記: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-4-methyl-L-leucine | 組成式: | C22 H36 N3 O7 P | SMILES: | c1ccc(COC(=O)NCP(=O)(O)NC(C(NC(C(=O)O)CC(C)(C)C)=O)CC(C)C)cc1 | InChi: | InChI=1S/C22H36N3O7P/c1-15(2)11-17(19(26)24-18(20(27)28)12-22(3,4)5)25-33(30,31)14-23-21(29)32-13-16-9-7-6-8-10-16/h6-10,15,17-18H,11-14H2,1-5H3,(H,23,29)(H,24,26)(H,27,28)(H2,25,30,31)/t17-,18-/m0/s1 | 別名: | (6S,9S)-1-(benzyloxy)-6-isobutyl-9-neopentyl-4-oxido-1,4,7-trioxo-2,5,8-triaza-4-phosphadecan-10-oate | 定義日: | 2015-09-25 | 最終更新日: | 2021-03-13 | 公開日: | 2015-10-28 | 識別子(ID): | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-4-methyl-L-leucine |
|